project id: TCGA-STAD; case submitter id: TCGA-HF-A5NB; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.86; rna integrity number: 9.1; age at index: 75; days to birth: -27676; ethnicity: not reported; gender: female; race: not reported; vital status: Alive; age at diagnosis: 27676; ajcc pathologic m: M0; ajcc pathologic n: N3a; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T4a; ajcc staging system edition: 7th; classification of tumor: not reported; days to last follow up: 928.0; icd 10 code: C16.3; last known disease status: not reported; morphology: 8480/3; primary diagnosis: Mucinous adenocarcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Gastric antrum; synchronous malignancy: No; tissue or organ of origin: Gastric antrum; tumor grade: Not Reported; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; initial weight: 280.0; portion submitter id: TCGA-HF-A5NB-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;